Aulnay-sous-Bois, France

Michel Jean-Charles Hardouin


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1977-1978

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michel Jean-Charles Hardouin: Innovator in X-ray Contrast Media

Introduction

Michel Jean-Charles Hardouin is a notable inventor based in Aulnay-sous-Bois, France. He has made significant contributions to the field of medical imaging, particularly through his innovative work on X-ray contrast media. With a total of 2 patents, Hardouin's inventions have advanced the capabilities of diagnostic imaging.

Latest Patents

Among his latest patents are the development of polyiods benzene derivatives and X-ray contrast media containing these compounds. The polyiods benzene derivatives relate to compounds of a specific formula, where R₁ can represent a hydrogen atom or a C₁-4 alkyl radical. The X-ray contrast media invention involves compounds characterized by a general formula, where n is an integer from 0 to 4, and R₁ and R₂ can represent various alkyl or hydroxyalkyl radicals. These compounds are particularly useful for myelography, enhancing the clarity and effectiveness of X-ray imaging.

Career Highlights

Throughout his career, Hardouin has worked with prominent companies in the pharmaceutical and medical imaging sectors. Notably, he has been associated with Laboratoires André Guerbet and Guerbet S.A., where he contributed to the development of innovative imaging solutions.

Collaborations

Hardouin has collaborated with esteemed colleagues, including Guy Tilly and Jean Lautrou, further enriching his work and contributions to the field.

Conclusion

Michel Jean-Charles Hardouin's innovative work in the development of X-ray contrast media and related compounds has significantly impacted medical imaging. His contributions continue to enhance diagnostic capabilities, making a lasting mark in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…